Nootropic / Anxiolytic Research
Selank 10mg
Selank peptide — the tuftsin-derived heptapeptide TKPRPGP, lyophilised. Preclinical work on GABA-A, enkephalinase and BDNF expression.
Vial size
Quantity
£59.98
£74.97
Save £14.99
In stockInc. VAT · Free UK shipping on this order
- Delivery.
- Free UK shipping on this order, Royal Mail Tracked 24. Same-day dispatch before 6pm. Details
- Payment.
- Card — including Apple Pay and Google Pay — or bank transfer approved in your banking app. We never see your card or bank details.
- Returns.
- 14 days to cancel if unopened and sealed (you pay return postage). Faulty, damaged or wrong items are replaced or refunded at our cost. Policy
Certificate of Analysis
Selank 10mg
- Independent lab
- an accredited independent laboratory
- Batch number
- —
- Method
- HPLC-UV + MS
- Result
- ≥98% HPLC
The CoA you download is the exact certificate produced for this lot — no edits.
Storage & handling
Keep it stable, keep it sterile
- Sealed vial
- -20°C, protect from light
- Once reconstituted
- Once reconstituted, store at 2–8°C (refrigerated). Use within 28 days. Do not refreeze after reconstitution.
- Diluent
- Bacteriostatic water (0.9% benzyl alcohol)
- Shipping
- Insulated, ice packs
About Selank
Selank is a synthetic heptapeptide analogue of the immunomodulatory tetrapeptide tuftsin, extended with a C-terminal Pro-Gly-Pro motif for protease resistance and developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It appears in the literature as Selank, as the sequence shorthand TKPRPGP, and under the development code TP-7. The published record is preclinical and predominantly conducted in rats: reported inhibition of enkephalin-degrading enzymes measured on plasma enkephalinase activity, reported effects on GABA-A receptor expression in the hippocampus rather than direct binding at the receptor, and regulation of BDNF expression following intranasal administration. Tuftsin signals through the receptor neuropilin-1; Selank has no identified receptor of its own, and whether the extension preserves that engagement is not established. PubMed indexes roughly 135 Selank records, against about 690 for tuftsin itself. No Western regulator has assessed the compound. Selank has a registration history in the Russian Federation and holds no MHRA, EMA or FDA authorisation. UK Peptides supplies it as ≥98% HPLC lyophilised powder with a signed third-party Certificate of Analysis, strictly for in-vitro and preclinical laboratory research. It is not a licensed medicine and is not for human or veterinary use.
Research areas
- GABA-A receptor expression
- Enkephalinase inhibition
- BDNF expression (rodent)
- Anxiolytic-pathway research (preclinical)
- Tuftsin lineage & immunomodulation
Every batch independently tested by an accredited independent laboratory before dispatch. The signed certificate for this lot is published on this page.
Legal notice
This product is sold strictly for in-vitro laboratory research purposes only. It is not approved for human or veterinary use, is not a drug, food, or cosmetic, and should not be misused as such. UK Peptides accepts no liability for misuse. By purchasing you confirm you are a qualified researcher aged 18 or over.
Selank 10mg
£59.98